Search Results

Bisphosphonates/various other drugs: Low-energy femoral fractures: 8 case reports

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 11-12(2)

Publisher: Adis International

Supportive Therapies in Multiple Myeloma

Authors: Gleason, Charise; Nooka, Ajay; Lonial, Sagar

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 7, Number 9, October 2009 , pp. 971-979(9)

Publisher: Cold Spring Publishing, LLC

Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases

Authors: Boonen, S.; Kay, R.; Cooper, C.; Haentjens, P.; Vanderschueren, D.; Callewaert, F.; Milisen, K.; Ferrari, S.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1792-1804(13)

Publisher: Blackwell Publishing

Bone signaling pathways and treatment of osteoporosis

Authors: Gogakos, Apostolos I; Cheung, Moira S; Bassett, JH Duncan; Williams, Graham R

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 6, November 2009 , pp. 639-650(12)

Publisher: Expert Reviews

Paget's disease of bone

Authors: Matthews, Brya; Cundy, Tim

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 6, November 2009 , pp. 651-668(18)

Publisher: Expert Reviews

Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates

Authors: Saad, Fred; Abrahamsson, Per-Anders; Miller, Kurt

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1573-1579(7)

Publisher: Blackwell Publishing

Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis

Authors: Planas, Jacques; Trilla, Enrique; Raventós, Carles; Cecchini, Lluis; Orsola, Anna; Salvador, Carles; Placer, Jose; Encabo, Gloria; Morote, Juan

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1637-1640(4)

Publisher: Blackwell Publishing

Bisphosphonates and the risk of ONJ

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 3-3(1)

Publisher: Adis International

Bisphosphonates and oral surgery

Author: Oliver, R.

Source: Oral Surgery, Volume 2, Number 2, May 2009 , pp. 56-63(8)

Publisher: Blackwell Publishing

Understanding the EORTC QLQ-BM22, the module for patients with bone metastases

Authors: Chow, Edward; Bottomley, Andrew

Source: Expert Review of Pharmacoeconomics and Outcomes Research, Volume 9, Number 5, October 2009 , pp. 461-465(5)

Publisher: Expert Reviews

Founders lecture 2007: Metabolic bone disease: what has changed in 30 years?

Author: Sundaram, Murali

Source: Skeletal Radiology, Volume 38, Number 9, September 2009 , pp. 841-853(13)

Publisher: Springer

Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases

Authors: Kawatani, Makoto; Osada, Hiroyuki

Source: Cancer Science, Volume 100, Number 11, November 2009 , pp. 1999-2005(7)

Publisher: Blackwell Publishing

Bisphosphonates/prednisolone/warfarin: Glucocorticoid-induced osteoporosis and various other toxicities in an elderly patient: case report

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 13-13(1)

Publisher: Adis International

Bisphosphonates: Osteonecrosis of the jaw treated with teriparatide: case report

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 13-13(1)

Publisher: Adis International

Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression

Authors: Binkley, N.; Silverman, S.; Simonelli, C.; Santiago, N.; Kohles, J.; Dasic, G.; Sunyecz, J.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1595-1601(7)

Publisher: Springer

Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures

Authors: Sheehy, O.; Kindundu, C.; Barbeau, M.; LeLorier, J.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1583-1594(12)

Publisher: Springer

Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women

Authors: Bharadwaj, S.; Naidu, A.; Betageri, G.; Prasadarao, N.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1603-1611(9)

Publisher: Springer

Bisphosphonates look best for osteoporosis in Thai women

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 590, 2009-10-31 , pp. 5-5(1)

Publisher: Adis International

Clinical efficacy and safety of zoledronic acid in osteoporosis and Paget's bone disease

Author: Doggrell, Sheila A

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 5, September 2009 , pp. 405-415(11)

Publisher: Expert Reviews

Paget's disease of bone: emphasis on treatment with zoledronic acid

Authors: Polyzos, Stergios A; Anastasilakis, Athanasios D; Terpos, Evangelos

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 5, September 2009 , pp. 423-434(12)

Publisher: Expert Reviews